StoneX maintains Westrock Coffee at Buy, raises price target to $12 from $10

StoneX reaffirmed its Buy rating for Westrock Coffee and increased its price target to $12 from $10, suggesting a 33.5% upside from the Nov 6 close of $8.99.

Original reporting
Published Nov 9, 2026, 3:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 9, 2026, 3:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
StoneX maintains Westrock Coffee at Buy, raises price target to $12 from $10 — source image
Decision brief

The 30-second read

Low
01

Why it matters

The price‑target increase could attract short‑term interest but the effect may be muted due to low trading volume.

02

Market read

A modest analyst upgrade for a micro‑cap stock; limited broader market impact.

03

What to watch

Liquidity constraints and limited analyst coverage could delay any price reaction.

Relevance 5/10Novelty 4/10Timing: today

Background

StoneX is an independent brokerage that provides research coverage for micro‑cap stocks.

Market effects

Minimal; the target change is specific to Westrock Coffee and does not affect the broader coffee or consumer sector.

None; the news is company‑specific.

Low; limited to investors tracking small‑cap equities.

Counterpoint

The target raise may be premature if the company's fundamentals do not support the higher valuation.

Key entities

  • StoneX

    Research provider that issued the upgraded target.

  • Westrock Coffee

    Micro‑cap coffee retailer whose stock is being re‑rated.

Related articles

$BLSHHighAI 8/10

Bullish stock initiated at Buy by StoneX on tokenization potential

StoneX initiated coverage on Bullish (NYSE:BLSH) with a Buy rating and $42 price target, citing tokenization potential. The company's shares have fallen 48% since September, trading at $21.31. Bullish plans to acquire Equiniti, positioning it as a transfer agent for public companies. Analysts have mixed views on the acquisition, with some upgrading and others lowering targets.

$WESTHighAI 8/10

Westrock Coffee (WEST) Q3 2026 Earnings Call Transcript

Westrock Coffee (WEST) reported Q3 2026 earnings, with net sales of $300M, down 15.4% YoY, but up 8% for the first nine months. Adjusted EBITDA rose 14% YoY to $26.4M. The company expects 2026 EBITDA of $90M-$100M, up 36% YoY, and $130M in 2027. Conway facility is at 40% capacity, with plans to reach 85% in 18 months, potentially doubling EBITDA. The company also secured a $600M refinancing deal.

$WESTMedAI 8/10

Westrock Coffee Co (WEST) (Q3 2026) Earnings Call Highlights: Record EBITDA, Conway Ramp

WestRock Coffee (WEST) reported Q3 2026 earnings, with CEO Scott Ford highlighting record EBITDA and debt paydown as priorities. The company expects 2027 EBITDA of ~$130M, with Conway facility ramping up to 85% capacity. Ford emphasized gross margin expansion due to Conway's higher-margin mix. Net sales declined 15.4% YoY due to tariff refunds but rose 8% YoY excluding them. The company refinanced debt, reducing service costs.

$WESTHigh

Westrock Coffee falls as Q3 sales miss estimates (WEST:NASDAQ)

Westrock Coffee (WEST) reported Q3 sales below estimates, with a wider net loss than expected. Shares fell 12% despite growth in adjusted EBITDA and gross profit. The company kept its full-year earnings forecast and provided an initial outlook. According to the company, sales were $1.2B vs. $1.3B expected, with a net loss of $0.15 per share vs. $0.05 expected.

$WESTMed

Telsey raises Westrock Coffee stock price target on transformation progress

Telsey increased its price target for Westrock Coffee (WEST) to $13.00 from $11.00, citing progress in its transformation to a broader beverage platform. The stock has risen 165% in the past year. Westrock's Conway facility is operating at 40% capacity, with plans to reach 85% in 18 months. The company reported a Q3 2026 loss of $0.10 per share and revenue of $300.2 million, missing expectations, but achieved record EBITDA of $26.4 million.